Nxera Pharma Co., Ltd. (TYO:4565)
Japan
· Delayed Price · Currency is JPY 954.00
+17.00 (1.81%)
Jun 26, 2026, 3:30 PM JST
Nxera Pharma Employees
Nxera Pharma had 382 employees as of December 31, 2025. The number of employees increased by 8 or 2.14% compared to the previous year.
Employees
382
Change (1Y)
8
Growth (1Y)
2.14%
Revenue / Employee
96.69M JPY
Profits / Employee
-28.18M JPY
Market Cap
88.35B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Oncolys BioPharma | 44 |
| SanBio Company | 33 |
| PeptiDream | 645 |
| GNI Group | 990 |
| Healios K.K. | 75 |
| Cuorips | 56 |
| Japan Tissue Engineering | 200 |
| StemRIM | 45 |
Nxera Pharma News
- 18 days ago - Nxera Joins OpenFold AI Research Consortium Alongside Leading Global Pharmaceutical and AI Companies to Accelerate AI-enabled Drug Discovery - GlobeNewsWire
- 25 days ago - Nxera Pharma Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 27 days ago - Nxera's Vamorolone Granted Key Regulatory Designations Supporting Faster Access for Duchenne Muscular Dystrophy Patients in South Korea - GlobeNewsWire
- 4 weeks ago - Nxera's President & CEO to Participate in a ‘Fireside Chat' at the Jefferies New York Healthcare Conference 2026 - GlobeNewsWire
- 6 weeks ago - Nxera Pharma Announces Progress of Out-Licensing of GPCR-targeted Program and Participation in Series A Financing - GlobeNewsWire
- 7 weeks ago - Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology - GlobeNewsWire
- 2 months ago - Nxera Pharma Quarterly report: Q1 2026 - Filings
- 2 months ago - Nxera Pharma to Receive US$10 Million Milestone Payment from AbbVie under Collaboration Targeting Neurological Diseases - GlobeNewsWire